Companies /Healthcare

Artivion Inc

NYSE: AORT Medical Devices
$22.84
▼ $0.03 (−0.11%) today
Markets closed · 5:26pm ET

Fundamentals

Market Cap
$1.1B
Profit Margin
-0.7%
Revenue (TTM)
$471.5M
EPS (TTM)
$-0.06
52-Week Range
$19 – $48
Street Target
$42.15

About Artivion

Artivion, Inc., based in Kennesaw, Georgia, is a global leader in the development and distribution of medical devices and implantable human tissues. The company specializes in a wide range of products for cardiac, vascular, neurologic, and pulmonary procedures, including BioGlue for surgical adhesion, PhotoFix for cardiac repair, and various stent grafts for aortic diseases. Artivion also offers vascular grafts, hemostats for surgical bleeding, cardiac laser therapy, and prosthetic heart valves, catering to healthcare professionals and facilities. Originally known as CryoLife, Artivion rebranded in 2022, continuing its commitment to innovative medical solutions since 1984.

Latest Activity

House trade disclosureGilbert Ray Cisneros, Jr.
  • AMDAdvanced Micro Devices, Inc. (AMD)Partial sell$1K – $15KAug 18
  • AGIO150 Main Street Trust > Bank of America Agios Pharmaceuticals, Inc. - Common StoBuy$1K – $15KAug 20
  • APH150 Main Street Trust > Bank of America Amphenol Corporation Common Stock (APH)Buy$1K – $15KAug 18
  • APG150 Main Street Trust > Bank of America APi Group Corporation Common Stock (APG)Buy$1K – $15KAug 4
  • APP150 Main Street Trust > Bank of America Applovin Corporation - Class A Common StPartial sell$1K – $15KAug 18
  • AORT150 Main Street Trust > Bank of America Artivion, Inc. Common Stock (AORT)Buy$1K – $15KAug 20
  • ATRCAtriCure, Inc. - Common Stock (ATRC)Buy$1K – $15KAug 20
  • BSX150 Main Street Trust > Bank of America Boston Scientific Corporation Common StoBuy$1K – $15KAug 18
+ 42 more trades in this filing
Made public 37 days after the earliest trade

Fifty-eight transactions in one filing amount to a full portfolio rebuild: bigger-ticket buys in Microsoft, Eaton, Quanta Services and Globus Medical, funded partly by repeated Lamar Advertising sales and trims in AMD, Nvidia and Meta. The rotation leans toward power, infrastructure and medical devices while chip and ad-tech exposure comes down. Disclosed 37 days after the earliest trades.

Read more

AORT Coverage